These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 1863730)
1. Perioperative management of coronary artery bypass surgery in a patient with factor IX deficiency. Wilson CJ; Frankville D; Robinson B; Koch F; Lake CL J Cardiothorac Vasc Anesth; 1991 Apr; 5(2):160-2. PubMed ID: 1863730 [No Abstract] [Full Text] [Related]
2. Perioperative Management of Mild Hemophilia B During and After Coronary Artery Bypass Grafting: Challenges and Solutions. Fernando RJ; Farmer BE; Augoustides JG; Gardner JC; Johnson SD; Ha B; Friess JO; Luedi MM; Erdoes G; Miller PJ; Ripat C; Fabbro M J Cardiothorac Vasc Anesth; 2019 Feb; 33(2):549-555. PubMed ID: 30177475 [No Abstract] [Full Text] [Related]
3. Coronary artery bypass grafting in a patient with hemophilia B: continuous recombinant factor IX infusion as per the Japanese guidelines for replacement therapy. Suzuki T; Kawamoto S; Kumagai K; Adachi O; Kanda K; Ishikawa M; Okitsu Y; Harigae H; Kurosawa S; Saiki Y Gen Thorac Cardiovasc Surg; 2016 Aug; 64(8):481-3. PubMed ID: 25523881 [TBL] [Abstract][Full Text] [Related]
4. Off-pump technique and replacement therapy for coronary artery bypass surgery in a patient with hemophilia B. Fernández-Caballero M; Martinez MF; Oristrell G; Palmer N; SantamarÃa A J Thromb Thrombolysis; 2019 Aug; 48(2):299-302. PubMed ID: 31152365 [TBL] [Abstract][Full Text] [Related]
5. [Coronary artery bypass with extracorporeal circulation in a patient with hemophilia B]. Bukowski JG; De Brux JL; Ganascia B; Cottineau C; Jacob JP Ann Fr Anesth Reanim; 1996; 15(3):304-6. PubMed ID: 8758585 [TBL] [Abstract][Full Text] [Related]
6. Recombinant versus plasma-derived factor IX in the treatment of hemophilia B: proceedings of a meeting held in June 2003. Mathew P; Altisent C Blood Coagul Fibrinolysis; 2004 Jun; 15 Suppl 2():S1-3. PubMed ID: 15322449 [No Abstract] [Full Text] [Related]
7. Coronary artery bypass surgery, angioplasty and long term anti-platelet treatment in a type B hemophilia patient. Pesaro AE; Gaz MV; Karbstein R; Perin M; Serrano CV; Damico E Clinics (Sao Paulo); 2009; 64(8):822-3. PubMed ID: 19690670 [No Abstract] [Full Text] [Related]
8. Coronary bypass in a patient with hemophilia B, or Christmas disease. Case report. Tourbaf KD; Bettigole RE; Zizzi JA; Subramanian S; Andersen MN J Thorac Cardiovasc Surg; 1979 Apr; 77(4):562-9. PubMed ID: 311396 [TBL] [Abstract][Full Text] [Related]
9. The benefits of prophylaxis in patients with hemophilia B. Castaman G Expert Rev Hematol; 2018 Aug; 11(8):673-683. PubMed ID: 29909699 [TBL] [Abstract][Full Text] [Related]
10. Factor IX replacement in surgery and prophylaxis. Zakarija A Blood Coagul Fibrinolysis; 2004 Jun; 15 Suppl 2():S5-7. PubMed ID: 15322450 [TBL] [Abstract][Full Text] [Related]
11. [The situation of hemophiliacs in Sweden]. Nilsson IM Lakartidningen; 1981 Dec; 78(52):4725-8. PubMed ID: 6799720 [No Abstract] [Full Text] [Related]
12. BAX326 (recombinant coagulation factor IX) for the treatment and prophylaxis of hemophilia B. Windyga J; Abbuehl BE; Hafeman AE Expert Rev Hematol; 2014 Jun; 7(3):333-42. PubMed ID: 24832133 [TBL] [Abstract][Full Text] [Related]
13. [Prophylactic treatment of hemophilia B. Considerations a propos of a personal study]. Cortellaro M; Praga C Haematol Lat; 1969; 12(3):651-7. PubMed ID: 5396830 [No Abstract] [Full Text] [Related]
14. [Long-term low-dose secondary prophylaxis for severe and moderate hemophilia children with arthropathy in China: a single-center observation study]. Wu RH; Wu XY; Zhang NN; Zhao L; Zhang JS; Zhen YZ; Peng Y Zhonghua Xue Ye Xue Za Zhi; 2013 Jul; 34(7):632-4. PubMed ID: 23906463 [No Abstract] [Full Text] [Related]
15. Coronary artery bypass grafting in a patient with haemophilia B. Palanzo DA; Sadr FS Perfusion; 1995 Jul; 10(4):265-70. PubMed ID: 7488773 [TBL] [Abstract][Full Text] [Related]
16. Acute myelogenous leukemia in a patient with severe factor IX deficiency. Clark C; Gidvani VK Pediatr Blood Cancer; 2011 Jan; 56(1):156-7. PubMed ID: 20842752 [TBL] [Abstract][Full Text] [Related]
18. Monitoring once-weekly recombinant factor IX prophylaxis in hemophilia B with thrombin generation assay and factor IX activity. Nummi V; Jouppila A; Lassila R Int J Lab Hematol; 2017 Aug; 39(4):359-368. PubMed ID: 28406575 [TBL] [Abstract][Full Text] [Related]
19. [Hemophilia B and aortocoronary bypass]. Dimitrova A; Tsarianski G; Aleksandrov V; Kereshka P; Nachev G; Chirkov A Khirurgiia (Sofiia); 1995; 48(1):76-9. PubMed ID: 7474765 [TBL] [Abstract][Full Text] [Related]
20. Treatment of a patient with factor IX deficiency (hemophilia B) with coronary bypass surgery. Scharfman WB; Rauch AE; Ferraris V; Burkart PT J Thorac Cardiovasc Surg; 1993 Apr; 105(4):765-6. PubMed ID: 8469013 [No Abstract] [Full Text] [Related] [Next] [New Search]